Clinical Research and GCP Training Services in BRICS Countries

UK based MNC,Helix Research Center has announced CRO and GCP Training Services for the Global Biopharmaceutical,Medical Device ,Cosmetic Industry,WHO,NIH etc and Clinical Reseatch Professionals respectively in BRICS Nations
 
Feb. 27, 2011 - PRLog -- It is an established fact that Brazil,Russia,India,China and South Africa known as BRICS Countries
are believed to  be Emerging Markets for the Pharmaceutical,Biotechnology,Medical Device,Cosmetic,
Healthcare,Vocational Education and many other Enterprises.The acronym BRIC was first coined by
Jim O'Neill of Goldman Sachs in the year 2001 in a paper entitled 'Building Better Global Economic
BRICs'.Since almost 50% of the World's population live in these Emerging Markets  and many killer
diseases like CAD ( Caronary Artery Disease),DM ( Diabetes Mellitus),various forms of Cancer,
Infectious Diseases,Psychiatric Disorders etc are rampant in the Community causing Nightmares
for the Health Administrators ,there is a dire need for promoting R&D ( Research and Development)
endeavours, both by domestic and Foreign/Multinational Stakeholders.Since Safety and well being
of Clinical Trial Subjects is a top most priority and most important than even the Clinical Trial
itself,any Clinical Trial must be expedited in accordance with Guidelines and Regulations governing
Medical Research.Since Helix Research Center has an expertise in Conducting Global Clinical Trials
and providing Training for the Pre Clinical,Phase 0 to IV or Bio Availability & Bio Equivalance Study
teams and zeal to Harmonise the 'Interpretation of GCPs (Good Clinical Practices)' in any Clinical
Research environment,Medical Research and Educational Services are being offered  for the
Prospectve clients in the BRICS Nations.


Brazil being the largest country in South America and fifth largest country in the World,both by
geographical area and population ( with over 190 million people),well developed Roads,Railways,
and State of the Art International Airpots in major cities like Rio De Janeiro,Sao Paulo etc with
good sample storage facilities, is definitely one of the preferred destinations for Global Clinical
Trials.Moreover,The National Health Surveillance Agency-ANVISA strives hard to protect
Human Rights and ensure strict GCP compliance whilst providing necessary Guidelines for
the Researchers to comply with law of the land in conducting Clinical Trials.The Ethics Committee
Members are not against 'Expedited Reviews' if convinced of the need.The Principal Investigators
and their support teams are known for completing the subject enrollents within Timelines and
Subject Retention rate is quiate encouraging and at par with any of the North American or European
Sites.


The Eurasia country Russia which is largest country in the World,covering more than 1/9th of the
Earth's land mass with an excellent Railways,Roadways and quite busy Domestic as well as International
Airports (Moscow,St.Petersburg,Khabarovsk etc),with World class Hospitals with a potential to
provide 'Medical Tourism 'Services for the rest of the World has been in the news for being
the favorite country for setting up R&D Units by some of major European and North American
Biopharma giants .The Clinicians of various Therapeutic areas work hard to comply with ICH Guidelines
and Regulations of Russian Ministry of Health and EMEA,FDA etc.There are millions of eligible Life Sciences
Graduates,Post Graduates,PhD who can be nurtured to become competent Clinical Research Professionals,
(Clinical Research Associates,Clinical Research Coordiators,Pharmacovigiance Professionals etc) who can
persue Clinical Research Careers both in Europe and Asia.


India,the second most populous country in the World with over one million Doctors of belonging to
various specialities has become one of the 'Hub' for Global Clinical Trials and also for establishing
R&D Units by major Pharma companies of the World.Clinical Research has become one of the most
preferred Careers for the Life Sciences candidates passing out from over 17,000 Life Sciences Colleges
teaching various Science Disciplines.The Roadways,Railways,Airways in India are well developed and cover
the length and breadth of the country.The policies of Ministry of Health,Govt of India have been very
encouraging for the stakeholders of New Drug Discovery and ICMR (Indian Coouncil for Medical Research)
and its division DCGI ( Drug Controller General of India),the Drug  Regulatory Authority in India ,have been
working hard to ensure Clinical Trial Subject Protection and provide necessary Guidelines for Research
Community to adhere to GCP Compliance.


China,the most populous country in the World is already well known for quicker patient enrollment rate
when ever a Global Clinical Trial is placed at any of the Hospitals either in mainland China or Hong Kong.
Since China has well developed Transport system such as High ways,Inlad Water ways,Railways,Airways,
and provision of sample storage is available ,multicentric Trials can be conducted in various major and medium sized
cities.Since there are many Medical Colleges and Hospitals in China,owned by both Public as well as Private sector,
there is a large pool of Q   ualified Clinicians  to take up a Global study.The State Food and Drug Administration-
(SFDA) ,the Regulatory Authority in China for Drugs,Devices,Food ,Cosmetics etc works hard to maintain the
balance of Strict GCP Compliance and Promotion of New Drug Discovery and Marketing.The second largest number
of Scientific papers are published by Chinese Researchers( first being USA) and China has a huge pool of Biologists.


South Africa (SA),the most prosperous country in the African Continent was included in the BRIC Countries list(2010)
making the acronym 'BRICS'.Having many qualified Clinicians from Public as well as Private Healthcare sectors,
SA has become one of the important Hubs for Global Clinical Trials.Moreover,the Government policy to promote
Clinical Research has been very encouraging for the Multinational companies to establish their Units and also
place their current Trials there.The South African 'Medicines Control Council (MCC)- Drug Regulatory Authority ,
SACRA-South African Clinical Research Association,etc have been working hard to R&D iniatives in SA.
Since South Africa has quite impressive transport and sample storage system indeed.There is a scope for nurturing
the taent of aspirng Life Sciences Graduates by providing GCP Training.


Helix Research Center will provide both Scientific as well as Therapeutic Research Services for the Global
Sponsors and GCP Training for the Life Sciences Prospects including Dcotors and Nurses.Since English is not a
main language in many of the BRICS Countries,Ireland based Translation company ,Simultrans which has
an expertise to offer Translation Services in over 80 + Languages and a strategic partner of Helix will provide
Translation Services as and when required.Helix will also provide Certificate Courses in Sleep Medicine in association
with Atlanta of School of Sleep Medicine and Technology,USA and Management Programs for Senior Executives,Sales Teams etc.
Helix is always keen to team with like minded groups and Organisations to promote New Drug Discovery,Preventive & Curative Healthcare
in any part of the World.

# # #

Helix Research Center Ltd is a London(UK) based global company offering Contract Research,Training,Auditing,Consulting,Medical Writing,Pharmacovigilance,Biostatistics,SMO,Regulatory Affairs,Quality Assurance,Publications,Translation ,CDM services globally
End
Helix Research Center Ltd News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share